Adenocarcinoma Of Esophagus: all 354 studies
Page 3 of 4. Open to participants first (81), then studies with results posted, then the rest; newest registration first within each.
- Induction FLOT With CROSS CRT for Esophageal CancerActive, not recruitingNCT04028167Phase 2
- Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal AdenocarcinomaStatus unknownNCT03995017Phase 1/2
- Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Active, not recruitingNCT03983954Phase 1
- Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid TumorsWithdrawnNCT03982173Phase 2
- Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal AdenocarcinomaCompletedNCT03961945Not applicable
- CAlorie and Protein REstriction PROgram in Barrett's Esophagus Patients (CARE-PRO).CompletedNCT03813381Not applicable
- Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerTerminatedNCT03809624Phase 1
- A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive MalignanciesStatus unknownNCT03789617Phase 1/2
- Prehabilitation of Patients With oEsophageal Malignancy Undergoing Peri-operative TreatmentStatus unknownNCT03626610Not applicable
- Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing SurgerySuspendedNCT03604991Phase 2/3
- Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal CancerWithdrawnNCT03592407Phase 2
- Siewert Type I-II: CT, PET-CT, EUS Sensitivity/Specificity for the Assessment of Lymph Node MetastasesCompletedNCT03529968
- DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal AdenocarcinomaCompletedNCT03526328
- Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerStatus unknownNCT03474341
- OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric CarcinomaCompletedNCT03429816Not applicable
- Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and SurvivalCompletedNCT03416101
- Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric CancerActive, not recruitingNCT03399071Phase 2
- Multiorgan Metabolic Imaging Response Assessment of AbemaciclibCompletedNCT03339843Phase 2
- Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CAWithdrawnNCT03307941Phase 1/2
- mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)Status unknownNCT03288350Phase 2
- The Microenvironment in Barrett's EsophagusCompletedNCT03060642
- Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and AdenocarcinomaCompletedNCT03015389
- WATS3D for the Detection of Esophageal DysplasiaCompletedNCT03008980
- Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or EsophagusTerminatedNCT02991547
- Exercise Prior to OesophagectomyStatus unknownNCT02962219Not applicable
- Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal CancerActive, not recruitingNCT02962063Phase 1/2
- Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux DiseaseCompletedNCT02890979Not applicable
- Influence of Central Obesity on the Esophageal Epithelial BarrierCompletedNCT02776982Not applicable
- Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal MalignanciesTerminatedNCT02638909Phase 2
- Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac CancerStatus unknownNCT02628665Phase 3
- Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTCCompletedNCT02610764Not applicable
- Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal CancerCompletedNCT02606396Not applicable
- ESD for the Treatment of Early Barrett's NeoplasiaStatus unknownNCT02583087
- Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the EsophagusActive, not recruitingNCT02509286Phase 3
- Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated NeoplasiaStatus unknownNCT02464930
- Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach CancerSuspendedNCT02366819Phase 4
- C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal CancerWithdrawnNCT02344810Phase 1/2
- Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.CompletedNCT02241499Phase 2
- Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric CancerCompletedNCT02128243Phase 2
- Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient ManagementCompletedNCT02075905
- FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal AdenocarcinomaActive, not recruitingNCT02037048Phase 2
- Proton Beam Therapy to Treat Esophageal CancerTerminatedNCT02023541Phase 1
- Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid TumorsTerminatedNCT02016534Phase 2
- Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal AdenocarcinomaCompletedNCT01932580Phase 2
- Cryotherapy -BEATS-RF Ablation TrialCompletedNCT01882478
- Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric CancerTerminatedNCT01870791Phase 2
- Barrett's Esophagus Patient RegistryStatus unknownNCT01776346
- Effects of Chemotherapy on Muscle Mass and Exercise Performance in Patients With Oesophageal Cancer.CompletedNCT01742312
- Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric CancerCompletedNCT01671774Phase 1
- Nodal Status in Adenocarcinoma of the Esophagus an CardiaCompletedNCT01635595
- A In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive TractCompletedNCT01630798Phase 1
- Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric CancerCompletedNCT01630083Phase 2
- Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT01561014Phase 1
- Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ AdenocarcinomaCompletedNCT01404156Phase 2/3
- Esophageal Protocol for Detection of Neoplasia in the Digestive TractCompletedNCT01391208Phase 1
- Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After ChemotherapyCompletedNCT01243398Phase 3
- Sorafenib. ICORG 06-41, V4CompletedNCT01158287Phase 2
- Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT01107639Phase 3
- Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett EsophagusStatus unknownNCT00987857Not applicable
- Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach CancerCompletedNCT00978549Phase 3
- Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal AdenocarcinomaStatus unknownNCT00964080Phase 1/2
- Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerStatus unknownNCT00963092
- Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal TissueCompletedNCT00909350
- Tethered Capsule Endoscope in Screening Participants for Barrett EsophagusStatus unknownNCT00903136Phase 1/2
- UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerCompletedNCT00900094
- Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and SurgeryCompletedNCT00898495
- Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal CancerCompletedNCT00861094Phase 2/3
- Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00732745Phase 1
- Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor TypesCompletedNCT00633789Phase 2
- Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal CancerStatus unknownNCT00628784Phase 4
- Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerCompletedNCT00628368Not applicable
- Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00601692Phase 1
- Endoscopic Tri-Modal Imaging in Patients With Barrett's EsophagusCompletedNCT00586989
- Endoscopic Mucosal Resection (EMR) in Barrett's EsophagusCompletedNCT00586872
- Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT00544362Phase 1/2
- Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerCompletedNCT00537121Phase 1
- Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal CancerTerminatedNCT00524186Phase 1
- Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal CancerCompletedNCT00520091Phase 2
- Studying Genes for Barrett's Esophagus in Brothers and SistersStatus unknownNCT00516347
- Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal CancerStatus unknownNCT00509561Phase 2/3
- Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT00445861Phase 1/2
- Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction CancerWithdrawnNCT00372450Not applicable
- Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryTerminatedNCT00290719Phase 1
- Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal CancerCompletedNCT00281736Phase 2
- Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction CancerCompletedNCT00258323Phase 2
- Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By SurgeryTerminatedNCT00258297Phase 2
- Doxil Topotecan Doublet Cancer StudyCompletedNCT00252889Phase 1
- Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By SurgeryCompletedNCT00238407Phase 2
- Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal AdenocarcinomaCompletedNCT00220103Phase 2
- Vinorelbine in Unresectable or Metastatic Esophageal and Gastric AdenocarcinomaCompletedNCT00215462Phase 2
- Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal CancerCompletedNCT00165490Phase 2
- Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or EsophagusCompletedNCT00165191Phase 2
- Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric CancerCompletedNCT00113581Phase 1
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00107341Phase 2
- RAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaCompletedNCT00101972Phase 1
- Gefitinib in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00100945Phase 2
- FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction CancerTerminatedNCT00098527Phase 2
- Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerCompletedNCT00096083Phase 2
- Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal CancerTerminatedNCT00093652Phase 1/2
- 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionCompletedNCT00077545Phase 2